GUN / FDUSD

GUN / BNB

PORTAL / FDUSD

GUN / USDC

GUN / TRY

GUN / USDT

PORTAL / USDT

PORTAL / BTC

PORTAL / TRY

PORTAL / BNB

CHESS / USDC

CHESS / USDT

GALA / BTC

DATA / BTC

SHELL / BNB

ARK / TRY

ARK / USDT

VET / BTC

TRU / TRY

TRU / USDT

MAZDA LIMITED

PC JEWELLER LTD

SINDHU TRADE LINKS LTD

PARSVNATH DEVELOPER LTD

VERANDA LEARNING SOL LTD

J.G.CHEMICALS LIMITED

EIMCO ELECON (INDIA) LTD

ORIENT CERATECH LIMITED

EMAMI PAPER MILLS LIMITED

CAPITAL TRUST LTD

COOL CAPS INDUSTRIES LTD

REMUS PHARMACEUTICALS L

SHARDA MOTOR INDS LTD

IRIS CLOTHINGS LIMITED

PARAS DEF AND SPCE TECH L

CONTAINER CORP OF IND LTD

DREAMFOLKS SERVICES LTD

TRENT LTD

NUVAMA WEALTH MANAGE LTD

KRISHANA PHOSCHEM LIMITED

Click here to get full coverage on DIVISLAB Outlook for the Week (July 07, 2025 – July 11, 2025) - Equitypandit

DIVISLAB Outlook for the Week (July 07, 2025 – July 11, 2025)  Equitypandit

DIVISLAB Outlook for the Week (July 07, 2025 – July 11, 2025) - Equitypandit

Click here to get full coverage on Divi's Laboratories (NSE:DIVISLAB) jumps 5.4% this week, though earnings growth is still tracking behind five-year shareholder returns - simplywall.st

Divi's Laboratories (NSE:DIVISLAB) jumps 5.4% this week, though earnings growth is still tracking behind five-year shareholder returns  simplywall.st

Divi's Laboratories (NSE:DIVISLAB) jumps 5.4% this week, though earnings growth is still tracking behind five-year shareholder returns - simplywall.st

Click here to get full coverage on Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - TradingView

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold?  TradingView

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - TradingView

Click here to get full coverage on Divis Lab gains after Q4 PAT climbs 23% YoY; recommends final dividend of Rs 30/ share - Business Standard

Divis Lab gains after Q4 PAT climbs 23% YoY; recommends final dividend of Rs 30/ share  Business Standard

Divis Lab gains after Q4 PAT climbs 23% YoY; recommends final dividend of Rs 30/ share - Business Standard

Click here to get full coverage on Transcript : Divi's Laboratories Limited, Q4 2025 Earnings Call, May 17, 2025 - MarketScreener

Transcript : Divi's Laboratories Limited, Q4 2025 Earnings Call, May 17, 2025  MarketScreener

Transcript : Divi's Laboratories Limited, Q4 2025 Earnings Call, May 17, 2025 - MarketScreener

Click here to get full coverage on Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict  Mint

Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict - Mint

Click here to get full coverage on Divi's Laboratories Limited (NSE:DIVISLAB) Investors Are Less Pessimistic Than Expected - simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Investors Are Less Pessimistic Than Expected  simplywall.st

Divi's Laboratories Limited (NSE:DIVISLAB) Investors Are Less Pessimistic Than Expected - simplywall.st

Click here to get full coverage on Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest? - The Economic Times

Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest?  The Economic Times

Divi’s Lab shares up 3% after Q4 PAT surges 26% YoY. Should you invest? - The Economic Times

Click here to get full coverage on Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend  CNBC TV18

Divi’s Labs Q4 Results: Profit up 23% YoY, beats estimates; declares ₹30 dividend - CNBC TV18

Click here to get full coverage on NSE DIVISLAB – Will Price Hit the Final Target? - Moneymunch

NSE DIVISLAB – Will Price Hit the Final Target?  Moneymunch

NSE DIVISLAB – Will Price Hit the Final Target? - Moneymunch

Click here to get full coverage on Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target - Moneycontrol

Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target  Moneycontrol

Divi's Labs hits record high after Citi initiates 'buy' call with most bullish price target - Moneycontrol

Click here to get full coverage on Accumulate Divis Laboratories; target of Rs 7518: Deven Choksey - TradingView

Accumulate Divis Laboratories; target of Rs 7518: Deven Choksey  TradingView

Accumulate Divis Laboratories; target of Rs 7518: Deven Choksey - TradingView

Click here to get full coverage on Divis Lab spurts as broker maintains buy call - Business Standard

Divis Lab spurts as broker maintains buy call  Business Standard

Divis Lab spurts as broker maintains buy call - Business Standard

Click here to get full coverage on Divi's Lab stock slips on US supply worries - The Economic Times

Divi's Lab stock slips on US supply worries  The Economic Times

Divi's Lab stock slips on US supply worries - The Economic Times

Click here to get full coverage on With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently  simplywall.st

With 49% ownership in Divi's Laboratories Limited (NSE:DIVISLAB), insiders continue to have the largest holding even though they have sold shares recently - simplywall.st

Click here to get full coverage on Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB  Moneymunch

Wave Outlook – NSE NIFTY & DIVISLAB - Moneymunch

Click here to get full coverage on Divi's Labs says 'no material impact' due to Novartis losing appeal in US district court - CNBC TV18

Divi's Labs says 'no material impact' due to Novartis losing appeal in US district court  CNBC TV18

Divi's Labs says 'no material impact' due to Novartis losing appeal in US district court - CNBC TV18

Click here to get full coverage on Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25%  The Economic Times

Divi's Labs Q3 Results: Cons PAT jumps 64% YoY to Rs 589 crore, revenue up 25% - The Economic Times

Click here to get full coverage on Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy - simplywall.st

Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy  simplywall.st

Divi's Laboratories Insiders Sold ₹620m Of Shares Suggesting Hesitancy - simplywall.st

Click here to get full coverage on Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors?  Business Standard

Divi's Laboratories shares slip 6% in trade; what's worrying investors? - Business Standard

Click here to get full coverage on Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold?  The Economic Times

Divi's Labs shares up 6% after Q3 PAT jumps 64% YoY. Should you buy, sell, or hold? - The Economic Times

Click here to get full coverage on Divis Laboratories Q2 results: Profit and EBITDA jump over 45% beating Street estimates - CNBC TV18

Divis Laboratories Q2 results: Profit and EBITDA jump over 45% beating Street estimates  CNBC TV18

Divis Laboratories Q2 results: Profit and EBITDA jump over 45% beating Street estimates - CNBC TV18

Click here to get full coverage on Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target - CNBC TV18

Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target  CNBC TV18

Divi's Labs exits the Nifty and gets a 'buy' recommendation with its highest target - CNBC TV18

Click here to get full coverage on Anil Singhvis Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Anil Singhvis Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside  Zee Business

Anil Singhvis Stock Strategy Revealed, Divis Lab, Eternal Futures Target, Stoploss Inside - Zee Business

Click here to get full coverage on Here’s why Divi’s Laboratories stock faced pressure on Tuesday - CNBC TV18

Here’s why Divi’s Laboratories stock faced pressure on Tuesday  CNBC TV18

Here’s why Divi’s Laboratories stock faced pressure on Tuesday - CNBC TV18

Click here to get full coverage on Divi's Labs: Strong Q3, growth outlook positive, valuation debate continues - Business Standard

Divi's Labs: Strong Q3, growth outlook positive, valuation debate continues  Business Standard

Divi's Labs: Strong Q3, growth outlook positive, valuation debate continues - Business Standard

Click here to get full coverage on Divi's Labs Q2 Results: Net profit rises 46% to Rs 510 crore, revenue at Rs 2,338 crore - Moneycontrol

Divi's Labs Q2 Results: Net profit rises 46% to Rs 510 crore, revenue at Rs 2,338 crore  Moneycontrol

Divi's Labs Q2 Results: Net profit rises 46% to Rs 510 crore, revenue at Rs 2,338 crore - Moneycontrol

Click here to get full coverage on F&O Insights: IPCA, Divis Lab see bullish bets; 24,700 the key for Nifty - Business Standard

F&O Insights: IPCA, Divis Lab see bullish bets; 24,700 the key for Nifty  Business Standard

F&O Insights: IPCA, Divis Lab see bullish bets; 24,700 the key for Nifty - Business Standard

Click here to get full coverage on Stock Radar: Infosys, SBI, Britannia Industries, Titan, Divis Lab, JK Tyres and others in focus - Moneycontrol

Stock Radar: Infosys, SBI, Britannia Industries, Titan, Divis Lab, JK Tyres and others in focus  Moneycontrol

Stock Radar: Infosys, SBI, Britannia Industries, Titan, Divis Lab, JK Tyres and others in focus - Moneycontrol

Click here to get full coverage on Divis Labs Q1 Results: Net profit rises 21% to Rs 430 crore, misses estimates - Moneycontrol

Divis Labs Q1 Results: Net profit rises 21% to Rs 430 crore, misses estimates  Moneycontrol

Divis Labs Q1 Results: Net profit rises 21% to Rs 430 crore, misses estimates - Moneycontrol

Click here to get full coverage on Divi's Lab share price: Why experts are bullish on this pharma stock? - Mint

Divi's Lab share price: Why experts are bullish on this pharma stock?  Mint

Divi's Lab share price: Why experts are bullish on this pharma stock? - Mint

Click here to get full coverage on Market extends gains as SENSEX reclaims the 82,200 mark; these three stocks hit a fresh 52-week high on Wednesday - Upstox

Market extends gains as SENSEX reclaims the 82,200 mark; these three stocks hit a fresh 52-week high on Wednesday  Upstox

Market extends gains as SENSEX reclaims the 82,200 mark; these three stocks hit a fresh 52-week high on Wednesday - Upstox

Click here to get full coverage on Nifty Next 50 Stock TO BUY: Divi's Lab is top pharma pick by Citi; know why - ET Now

Nifty Next 50 Stock TO BUY: Divi's Lab is top pharma pick by Citi; know why  ET Now

Nifty Next 50 Stock TO BUY: Divi's Lab is top pharma pick by Citi; know why - ET Now

Click here to get full coverage on Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix - Moneycontrol

Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix  Moneycontrol

Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix - Moneycontrol

Click here to get full coverage on Divi's Labs: Downgrade cycle over! BofA upgrades stock to Buy, shares target price - Business Today

Divi's Labs: Downgrade cycle over! BofA upgrades stock to Buy, shares target price  Business Today

Divi's Labs: Downgrade cycle over! BofA upgrades stock to Buy, shares target price - Business Today

Click here to get full coverage on Why Divis Lab Share Price is Falling - Equitymaster

Why Divis Lab Share Price is Falling  Equitymaster

Why Divis Lab Share Price is Falling - Equitymaster

Click here to get full coverage on Ganesh Chaturthi Stock Picks 2024: BEL, Divi's Labs, Indus Towers among analysts' top buy and sell recommendations - Zee Business

Ganesh Chaturthi Stock Picks 2024: BEL, Divi's Labs, Indus Towers among analysts' top buy and sell recommendations  Zee Business

Ganesh Chaturthi Stock Picks 2024: BEL, Divi's Labs, Indus Towers among analysts' top buy and sell recommendations - Zee Business

Click here to get full coverage on Divi's Laboratories Q4 Results: Net profit rises 67% to ₹538 crore, revenue up 18% YoY; dividend declared - Mint

Divi's Laboratories Q4 Results: Net profit rises 67% to ₹538 crore, revenue up 18% YoY; dividend declared  Mint

Divi's Laboratories Q4 Results: Net profit rises 67% to ₹538 crore, revenue up 18% YoY; dividend declared - Mint

Click here to get full coverage on Divi's Lab, LTIMindtree shares jump despite exclusion from Nifty 50 index - Moneycontrol

Divi's Lab, LTIMindtree shares jump despite exclusion from Nifty 50 index  Moneycontrol

Divi's Lab, LTIMindtree shares jump despite exclusion from Nifty 50 index - Moneycontrol

Click here to get full coverage on Divis Laboratories Ltd Stock Price: Divis Lab. Share Price Today - India Infoline

Divis Laboratories Ltd Stock Price: Divis Lab. Share Price Today  India Infoline

Divis Laboratories Ltd Stock Price: Divis Lab. Share Price Today - India Infoline

Click here to get full coverage on Divis Lab closed today at ₹3156.3, down -3.4% from yesterday's ₹3267.25 - Mint

Divis Lab closed today at ₹3156.3, down -3.4% from yesterday's ₹3267.25  Mint

Divis Lab closed today at ₹3156.3, down -3.4% from yesterday's ₹3267.25 - Mint

Click here to get full coverage on Divi’s Lab, one of best performing large-cap stocks, sees wave of bullish calls - Mint

Divi’s Lab, one of best performing large-cap stocks, sees wave of bullish calls  Mint

Divi’s Lab, one of best performing large-cap stocks, sees wave of bullish calls - Mint

Click here to get full coverage on Divi's Laboratories Q3 Results: Pharma major sees 17% jump in profit to Rs 358 crore - Business Today

Divi's Laboratories Q3 Results: Pharma major sees 17% jump in profit to Rs 358 crore  Business Today

Divi's Laboratories Q3 Results: Pharma major sees 17% jump in profit to Rs 358 crore - Business Today

Click here to get full coverage on Divi's Lab, Syngene International, other pharma CDMO stocks fall as US softens stance on Biosecure Act - Upstox

Divi's Lab, Syngene International, other pharma CDMO stocks fall as US softens stance on Biosecure Act  Upstox

Divi's Lab, Syngene International, other pharma CDMO stocks fall as US softens stance on Biosecure Act - Upstox

Click here to get full coverage on Divis Lab closed today at ₹3265.55, up 5.42% from yesterday's ₹3097.75 - Mint

Divis Lab closed today at ₹3265.55, up 5.42% from yesterday's ₹3097.75  Mint

Divis Lab closed today at ₹3265.55, up 5.42% from yesterday's ₹3097.75 - Mint

Click here to get full coverage on Analyst call tracker: Analysts increasingly bearish on Divi's Labs, Dr Reddy's - Moneycontrol

Analyst call tracker: Analysts increasingly bearish on Divi's Labs, Dr Reddy's  Moneycontrol

Analyst call tracker: Analysts increasingly bearish on Divi's Labs, Dr Reddy's - Moneycontrol

Click here to get full coverage on Pharma stock jumps over 4% after signing long-term supply deal with global pharma company - Trade Brains

Pharma stock jumps over 4% after signing long-term supply deal with global pharma company  Trade Brains

Pharma stock jumps over 4% after signing long-term supply deal with global pharma company - Trade Brains

Click here to get full coverage on Four injured in fire accident at Divis Lab - The Hindu

Four injured in fire accident at Divis Lab  The Hindu

Four injured in fire accident at Divis Lab - The Hindu

Click here to get full coverage on Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3755, up 2.05% from yesterday's ₹3679.45 - Mint

Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3755, up 2.05% from yesterday's ₹3679.45  Mint

Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3755, up 2.05% from yesterday's ₹3679.45 - Mint

Click here to get full coverage on Indian pharma industry: A comparative analysis of Sun Pharma and Divi's Laboratories - Upstox

Indian pharma industry: A comparative analysis of Sun Pharma and Divi's Laboratories  Upstox

Indian pharma industry: A comparative analysis of Sun Pharma and Divi's Laboratories - Upstox

Click here to get full coverage on Divi’s Lab share price tanks over 4% as SBI Mutual Fund cuts stake in the firm; check key details - Upstox

Divi’s Lab share price tanks over 4% as SBI Mutual Fund cuts stake in the firm; check key details  Upstox

Divi’s Lab share price tanks over 4% as SBI Mutual Fund cuts stake in the firm; check key details - Upstox

Click here to get full coverage on Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3657.55, down -1.29% from yesterday's ₹3705.2 - Mint

Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3657.55, down -1.29% from yesterday's ₹3705.2  Mint

Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3657.55, down -1.29% from yesterday's ₹3705.2 - Mint

Click here to get full coverage on Divis Laboratories (Nse) | Stock Share Price Live - MarketSmith India

Divis Laboratories (Nse) | Stock Share Price Live  MarketSmith India

Divis Laboratories (Nse) | Stock Share Price Live - MarketSmith India

Click here to get full coverage on Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3628.2, down -0.33% from yesterday's ₹3640.05 - Mint

Divis Lab share price Today Live Updates : Divis Lab closed today at ₹3628.2, down -0.33% from yesterday's ₹3640.05  Mint

Divi's Laboratories Limited (DIVISLAB)

Price Chart

Key Statistics

Technicals

About DIVISLAB

Latest News

DIVISLAB Outlook for the Week (July 07, 2025 – July 11, 2025) - Equitypandit

Divi's Laboratories (NSE:DIVISLAB) jumps 5.4% this week, though earnings growth is still tracking behind five-year shareholder returns - simplywall.st

Divi’s Laboratories shares rally 6% on strong Q4 show; should you buy, sell or hold? - TradingView

Advanced Charts

Top Gainers

Top Losers